Statin myopathy: Over-rated and under-treated

You'll have to demand your doctor figure out your myopathy.
http://www.mdlinx.com/internal-medicine/medical-news-article/2016/06/13/statin/6704352/?

Current Opinion in Cardiology, 06/13/2016Maghsoodi N, et al.

The purpose of this study is to conclude the definition of statin–related muscle disorders, causative factors, and recommended management strategies. Statin–related muscle adverse–effects are common. Secondary causes of muscle disease unmasked by statin therapy should be identified. Most patients can be managed by adjustment of standard treatment protocols.

• A number of consensus groups have defined and classified statin–related muscle disorders, whereas others have suggested diagnostic and management strategies. Mechanisms behind statin–related muscle toxicity have been identified.
• Therapeutic and clinical investigation pathways have been reviewed and algorithms defined.
• Novel drugs have become available to reduce low–density lipoprotein cholesterol levels that are not associated with causing muscle side–effects.

Go to PubMed Go to Abstract Print Article Summary Cat 2 CME Report